Please use this identifier to cite or link to this item: http://20.193.157.4:9595/xmlui/handle/123456789/1727
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDeepa S Sajjannar, Sanjeev L Sajjannar.-
dc.date.accessioned2020-01-16T09:58:19Z-
dc.date.available2020-01-16T09:58:19Z-
dc.date.issued2014-04-
dc.identifier.urihttp://hdl.handle.net/123456789/1727-
dc.description.abstractOsteoporosis is a systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Postmenopausal women due to the various hormonal factors are at increased risk. Bone mineral density (BMD) measurements are gold standard in calculating bone mass, the changes are usually late and the damage is irreversible. This study was done to evaluate the rate of bone loss in postmenopausal women by measuring Serum Total Alkaline Phosphatase (ALPen_US
dc.language.isoenen_US
dc.publisherBLDE(Deemed to be University)en_US
dc.subjectAlkaline Phosphatase, Calcium, Hydroxyprolineen_US
dc.titleStudy of serum alkaline phosphatase calcium and urinary hydroxyproline as bone biomarkers in postmenopausal women.en_US
dc.typeArticleen_US
Appears in Collections:Faculty of Biochemistry

Files in This Item:
File Description SizeFormat 
A645.pdf275.5 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.